Jiangsu Edison Biotechnology

Jiangsu Edison Biotechnology is a Chinese biotechnology company headquartered in the China Medical City (Taizhou), Jiangsu province. Founded in 2013, the company specializes in the research, development, and manufacturing of in vitro diagnostic (IVD) products, with a core focus on molecular diagnostics and point-of-care testing (POCT). Its product portfolio includes a range of diagnostic kits for infectious diseases, such as Human Papillomavirus (HPV), Hepatitis B (HBV), and Hepatitis C (HCV), as well as oncology-related molecular assays. The company utilizes advanced technologies including fluorescence quantitative PCR and isothermal amplification to provide high-sensitivity testing solutions. Jiangsu Edison Biotechnology operates GMP-compliant manufacturing facilities and primarily serves the domestic Chinese healthcare market, providing integrated diagnostic solutions for clinical laboratories and hospitals.